Sign Up Today and Learn More About Maze Therapeutics Stock
Invest in or calculate the value of your shares in Maze Therapeutics or other pre-IPO companies through EquityZen's platform.
Maze Therapeutics Stock
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
About Maze Therapeutics Stock
Founded
2018
Headquarters
South San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Maze Therapeutics Press Mentions
Stay in the know about the latest news on Maze Therapeutics
The Week’s Biggest Funding Rounds: Tenstorrent And Nuvig Top List
news • Dec 06, 2024
Atlas closes $450m biotech fund, and other financing news
pharmaphorum • Dec 06, 2024
Maze Therapeutics Raises $115M Series D
citybiz • Dec 04, 2024
Metabolic focus steers Maze to bumper Series D haul
thepharmaletter • Dec 04, 2024
Maze Therapeutics: $115 Million (Series D) Raised To Develop Precision Medicine
pulse2 • Dec 04, 2024
Maze Therapeutics Management
Leadership team at Maze Therapeutics
Board Member
Charles Homcy
Board Member
Vineeta Agarwala
Join now and verify your accreditation status to gain access to:
- Maze Therapeutics current valuation
- Maze Therapeutics stock price
- Available deals in Maze Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Maze Therapeutics Stock
How to invest in Maze Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Maze Therapeutics through EquityZen funds. These investments are made available by existing Maze Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Maze Therapeutics stock?
Shareholders can sell their Maze Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
